These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 16987696)
1. The effect of ionizing radiation of 1,4-dihydropyridine derivatives in the solid state. Naskrent M; Mielcarek J Spectrochim Acta A Mol Biomol Spectrosc; 2007 May; 67(1):251-5. PubMed ID: 16987696 [TBL] [Abstract][Full Text] [Related]
2. Thermal stability of 1,4-dihydropyridine derivatives in solid state. Marciniec B; Ogrodowczyk M Acta Pol Pharm; 2006; 63(6):477-84. PubMed ID: 17438863 [TBL] [Abstract][Full Text] [Related]
3. The effect of ionizing radiation on some derivatives of 1,4-dihydropyridine in the solid state. Marciniec B; Jaroszkiewicz E; Ogrodowczyk M Int J Pharm; 2002 Feb; 233(1-2):207-15. PubMed ID: 11897425 [TBL] [Abstract][Full Text] [Related]
4. Photo- and radiostability of some 1,4-dihydropyridine derivatives in the solid state. Marciniec B; Ogrodowczyk M Acta Pol Pharm; 2003; 60(2):151-5. PubMed ID: 13678328 [TBL] [Abstract][Full Text] [Related]
5. [Toxicological analysis of selected 1,4-dihydropyridine calcium channel blockers in the diagnosis of intoxications]. Wachowiak R; Strach B; Lopatka P Arch Med Sadowej Kryminol; 2005; 55(1):47-54. PubMed ID: 15984121 [TBL] [Abstract][Full Text] [Related]
13. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes. Furukawa T; Nukada T; Namiki Y; Miyashita Y; Hatsuno K; Ueno Y; Yamakawa T; Isshiki T Eur J Pharmacol; 2009 Jun; 613(1-3):100-7. PubMed ID: 19401195 [TBL] [Abstract][Full Text] [Related]
14. Oxidation of Hantzsch 1,4-dihydropyridines of pharmacological significance by electrogenerated superoxide. Ortiz ME; Núñez-Vergara LJ; Camargo C; Squella JA Pharm Res; 2004 Mar; 21(3):428-35. PubMed ID: 15070092 [TBL] [Abstract][Full Text] [Related]
15. Dihydropyridine calcium channel blockers and the progression of parkinsonism. Marras C; Gruneir A; Rochon P; Wang X; Anderson G; Brotchie J; Bell CM; Fox S; Austin PC Ann Neurol; 2012 Mar; 71(3):362-9. PubMed ID: 22451203 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of barnidipine: a single optical isomer dihydropyridine calcium antagonist. van Zwieten PA Blood Press Suppl; 1998; 1():5-8. PubMed ID: 9660520 [TBL] [Abstract][Full Text] [Related]
17. Normal-phase TLC separation of enantiomers of 1.4-dihydropyridine derivatives. Mielcarek J Drug Dev Ind Pharm; 2001 Feb; 27(2):175-9. PubMed ID: 11266230 [TBL] [Abstract][Full Text] [Related]
18. Anti-arrhythmic and hemodynamic effects of oxy nifedipine, oxy nimodipine, oxy nitrendipine and oxy nisoldipine. Mitręga KA; Varghese B; Porc M; Krzemiński TF Pharmacol Res; 2012 Oct; 66(4):300-8. PubMed ID: 22750214 [TBL] [Abstract][Full Text] [Related]
19. Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk? Beevers DG; Sleight P BMJ; 1996 May; 312(7039):1143-5. PubMed ID: 8620133 [No Abstract] [Full Text] [Related]
20. Correlation between predicted theoretical mechanistic biochemistry (TMB) data and therapeutic effects in the management of vascular disorders with calcium channel blockers. Akintonwa DA; Odigwe CO Med Hypotheses; 2000 Jun; 54(6):944-7. PubMed ID: 10867744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]